Cleared Traditional

K121944 - LIAISON DIRECT RENIN LIAISON CONTROL DIRECT RENIN LIAISON ENDOCRINOLOGY DILUENT

K121944 is an FDA 510(k) clearance for LIAISON DIRECT RENIN LIAISON CONTROL DI..., manufactured by DiaSorin, Inc.. The device is a Class 2 Chemistry device with product code CIB cleared through the Traditional 510(k) pathway after a 182-day FDA review.

K121944 · DiaSorin, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2013
Decision
182d
Days
Class 2
Risk

K121944 is an FDA 510(k) clearance for the LIAISON DIRECT RENIN LIAISON CONTROL DIRECT RENIN LIAISON ENDOCRINOLOGY DILUENT. Classified as Radioimmunoassay, Angiotensin I And Renin (product code CIB), Class II - Special Controls.

Submitted by DiaSorin, Inc. (Stillwater, US). The FDA issued a Cleared decision on January 1, 2013 after a review of 182 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1085 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all DiaSorin, Inc. devices

FDA 510(k) Submission Details - K121944

510(k) Number K121944 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 03, 2012
Decision Date January 01, 2013
Days to Decision 182 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
94d slower than avg
Panel avg: 88d · This submission: 182d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CIB Device Classification - Class 2, Special Controls

Product Code CIB Radioimmunoassay, Angiotensin I And Renin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1085
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CIB Radioimmunoassay, Angiotensin I And Renin

All 10
Devices cleared under the same product code (CIB) and FDA review panel - the closest regulatory comparables to K121944.
IDS ISYS DIRECT RENIN ASSAY, IDS ISYS DIRECT RENIN CONTROL SET, AND IDS ISYS DIRECT RENIN CALIBRATION VERIFIERS
K123763 · Immunodiagnostic Systems , Ltd. · Dec 2013
ACTIVE RENIN IRMA
K061758 · Diagnostic Systems Laboratories, Inc. · Jul 2006
NICHOLS ADVANTAGE DIRECT RENIN (CALIBRATORS, CALIBRATION VERIFIERS, CONTROLS, AND SAMPLE DILUENT)
K011128 · Nichols Institute Diagnostics · Sep 2001
ACTIVE RENIN IRMA MODEL NUMBER DSL-25100
K981607 · Diagnostic Systems Laboratories, Inc. · May 1998
ACTIVE RENIN IMMUNORADIOMETRIC ASSAY
K925998 · Nichols Institute Diagnostics · Jan 1993
RIANEN ANGIOTENSIN I RADIOIMMUNOASSAY KI
K850054 · E.I. Dupont DE Nemours & Co., Inc. · Mar 1985